Axon death signalling in Wallerian degeneration among species and in disease.


Journal

Open biology
ISSN: 2046-2441
Titre abrégé: Open Biol
Pays: England
ID NLM: 101580419

Informations de publication

Date de publication:
30 08 2019
Historique:
entrez: 29 8 2019
pubmed: 29 8 2019
medline: 1 5 2020
Statut: ppublish

Résumé

Axon loss is a shared feature of nervous systems being challenged in neurological disease, by chemotherapy or mechanical force. Axons take up the vast majority of the neuronal volume, thus numerous axonal intrinsic and glial extrinsic support mechanisms have evolved to promote lifelong axonal survival. Impaired support leads to axon degeneration, yet underlying intrinsic signalling cascades actively promoting the disassembly of axons remain poorly understood in any context, making the development to attenuate axon degeneration challenging. Wallerian degeneration serves as a simple model to study how axons undergo injury-induced axon degeneration (axon death). Severed axons actively execute their own destruction through an evolutionarily conserved axon death signalling cascade. This pathway is also activated in the absence of injury in diseased and challenged nervous systems. Gaining insights into mechanisms underlying axon death signalling could therefore help to define targets to block axon loss. Herein, we summarize features of axon death at the molecular and subcellular level. Recently identified and characterized mediators of axon death signalling are comprehensively discussed in detail, and commonalities and differences across species highlighted. We conclude with a summary of engaged axon death signalling in humans and animal models of neurological conditions. Thus, gaining mechanistic insights into axon death signalling broadens our understanding beyond a simple injury model. It harbours the potential to define targets for therapeutic intervention in a broad range of human axonopathies.

Identifiants

pubmed: 31455157
doi: 10.1098/rsob.190118
pmc: PMC6731592
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

190118

Références

Front Oncol. 2018 Dec 12;8:622
pubmed: 30631755
J Neurosci. 2013 Aug 14;33(33):13410-24
pubmed: 23946398
Neuron. 2003 Jul 17;39(2):217-25
pubmed: 12873380
Neuron. 2017 Mar 22;93(6):1334-1343.e5
pubmed: 28334607
Neurobiol Dis. 2013 Aug;56:34-46
pubmed: 23542511
Neurobiol Dis. 2011 Apr;42(1):1-8
pubmed: 21168501
Science. 2012 Jul 27;337(6093):481-4
pubmed: 22678360
Eur J Neurosci. 1989;1(1):27-33
pubmed: 12106171
PLoS Biol. 2013;11(4):e1001539
pubmed: 23610559
Sci Rep. 2016 Nov 15;6:37050
pubmed: 27845394
Sci Rep. 2017 Mar 07;7:43846
pubmed: 28266613
Cell Rep. 2016 Oct 11;17(3):774-782
pubmed: 27732853
Curr Biol. 2012 Apr 10;22(7):596-600
pubmed: 22425157
J Biol Chem. 2018 Sep 7;293(36):13897-13909
pubmed: 29997255
Curr Biol. 2012 Apr 10;22(7):590-5
pubmed: 22425156
J Cell Biol. 2007 Jan 29;176(3):269-75
pubmed: 17261846
Br J Anaesth. 2017 Oct 1;119(4):737-749
pubmed: 29121279
J Exp Med. 1987 Apr 1;165(4):1218-23
pubmed: 3559478
J Neurosci. 2000 Feb 15;20(4):1333-41
pubmed: 10662823
ILAR J. 2014;54(3):291-5
pubmed: 24615442
J Neurosci. 2006 Sep 20;26(38):9794-804
pubmed: 16988050
Front Neurosci. 2018 Oct 23;12:769
pubmed: 30405346
Dev Cell. 2019 Feb 25;48(4):506-522.e6
pubmed: 30745142
F1000Res. 2016 Apr 25;5:
pubmed: 27158461
Trends Biochem Sci. 2004 Dec;29(12):634-7
pubmed: 15544948
Neurotherapeutics. 2010 Jan;7(1):31-42
pubmed: 20129495
Brain Res Bull. 2009 Oct 28;80(4-5):217-23
pubmed: 19683034
J Cell Biol. 2017 Feb;216(2):477-493
pubmed: 28053206
Trends Neurosci. 2016 May;39(5):311-324
pubmed: 27040729
Nat Commun. 2015 Nov 30;6:10057
pubmed: 26616331
Biochem Biophys Res Commun. 2019 Jul 5;514(4):1037-1039
pubmed: 31097218
Neurobiol Dis. 2013 Nov;59:69-79
pubmed: 23892229
Brain. 2016 Apr;139(Pt 4):1094-105
pubmed: 26912636
Neuron. 2006 Jun 15;50(6):883-95
pubmed: 16772170
Cell Death Dis. 2018 Nov 2;9(11):1116
pubmed: 30389906
PLoS Biol. 2012;10(12):e1001440
pubmed: 23226106
Proc Natl Acad Sci U S A. 2018 Sep 11;115(37):E8746-E8754
pubmed: 30150401
Nat Commun. 2017 Feb 06;8:14355
pubmed: 28165006
J Neurosci. 2013 Aug 14;33(33):13569-80
pubmed: 23946415
Tissue Eng. 2001 Apr;7(2):131-9
pubmed: 11304449
J Neurosci. 2010 Oct 6;30(40):13291-304
pubmed: 20926655
Proc Natl Acad Sci U S A. 2018 Feb 6;115(6):1358-1363
pubmed: 29295933
PLoS Biol. 2006 Nov;4(12):e416
pubmed: 17132048
Proc Natl Acad Sci U S A. 2012 Dec 26;109(52):E3696-705
pubmed: 23188802
Neurosci Res. 2019 Feb;139:21-25
pubmed: 30118738
J Neurotrauma. 2015 Jun 1;32(11):780-90
pubmed: 25333317
iScience. 2019 May 31;15:452-466
pubmed: 31128467
Proc Natl Acad Sci U S A. 2000 Oct 10;97(21):11377-82
pubmed: 11027338
J Cell Biol. 2005 Aug 1;170(3):349-55
pubmed: 16043516
Brain. 2016 Dec;139(Pt 12):3092-3108
pubmed: 27797810
Cell Rep. 2017 Oct 3;21(1):10-16
pubmed: 28978465
Science. 2013 Jan 25;339(6118):452-6
pubmed: 23239625
Neurochem Int. 2010 Jan;56(1):101-6
pubmed: 19778564
Curr Biol. 2017 Mar 20;27(6):784-794
pubmed: 28262487
Nat Neurosci. 2001 Dec;4(12):1199-206
pubmed: 11770485
Trends Neurosci. 2002 Oct;25(10):532-7
pubmed: 12220882
J Neurosci. 2016 Apr 27;36(17):4681-9
pubmed: 27122027
PLoS One. 2015 Jun 25;10(6):e0131617
pubmed: 26111004
J Neurosci. 1995 Oct;15(10):6445-52
pubmed: 7472407
Exp Neurol. 2019 Oct;320:112958
pubmed: 31132363
Nat Med. 2005 May;11(5):572-7
pubmed: 15821747
J Cell Biol. 2009 Feb 23;184(4):501-13
pubmed: 19237597
Science. 2004 Aug 13;305(5686):1010-3
pubmed: 15310905
J Neurosci. 2009 Jan 21;29(3):653-68
pubmed: 19158292
Development. 2010 Dec;137(23):3985-94
pubmed: 21041367
Sci Adv. 2019 Feb 13;5(2):eaav4971
pubmed: 30788439
Hum Mol Genet. 2018 Nov 1;27(21):3761-3771
pubmed: 30010873
J Peripher Nerv Syst. 2017 Sep;22(3):162-171
pubmed: 28485482
Cell. 2015 Jan 15;160(1-2):161-76
pubmed: 25594179
Nat Rev Neurosci. 2014 Jun;15(6):394-409
pubmed: 24840802
Elife. 2017 Jan 18;6:
pubmed: 28098556
Curr Opin Neurol. 2018 Dec;31(6):693-701
pubmed: 30320612
Curr Biol. 2003 Apr 15;13(8):669-73
pubmed: 12699624
J Neurosci. 2009 Jan 14;29(2):444-53
pubmed: 19144844
Prog Neurobiol. 2009 Nov;89(3):231-9
pubmed: 19664679
Cell Death Differ. 2015 May;22(5):731-42
pubmed: 25323584
Neural Dev. 2012 Jun 08;7:19
pubmed: 22681863
J Biol Chem. 2005 Oct 28;280(43):36334-41
pubmed: 16118205
J Neurosci. 2014 May 21;34(21):7179-89
pubmed: 24849352
J Neurosci. 2011 Jan 19;31(3):966-78
pubmed: 21248121
Cell Rep. 2015 Dec 22;13(11):2539-2552
pubmed: 26686637
Open Biol. 2014 Apr 09;4:130219
pubmed: 24718597
J Neurosci. 2015 Nov 11;35(45):15026-38
pubmed: 26558774
Trends Cell Biol. 2014 Sep;24(9):515-23
pubmed: 24780172
PLoS Biol. 2010 Jan 26;8(1):e1000300
pubmed: 20126265
J Neurosci. 2013 Nov 27;33(48):18728-39
pubmed: 24285879
FEBS J. 2006 May;273(10):2077-99
pubmed: 16649987
Cell Rep. 2015 Mar 31;10(12):1974-81
pubmed: 25818290
Edinb Med Surg J. 1851 Oct 1;76(189):369-376
pubmed: 30332247
J Neurosci Res. 2010 Nov 15;88(15):3319-27
pubmed: 20857515
J Neurosci. 2009 May 20;29(20):6526-34
pubmed: 19458223
Brain Res. 1974 Apr 5;69(2):203-15
pubmed: 4823092
Cell Death Differ. 2013 Mar;20(3):478-89
pubmed: 23175186
Neuroscience. 2013 May 15;238:258-69
pubmed: 23485808
Elife. 2016 Oct 13;5:
pubmed: 27735788
Proc Natl Acad Sci U S A. 2014 Jul 8;111(27):9965-70
pubmed: 24958874
Nat Commun. 2016 Sep 20;7:12871
pubmed: 27647497
Neuroscience. 2012 Dec 6;225:44-54
pubmed: 22960623
J Exp Med. 2019 Feb 4;216(2):294-303
pubmed: 30642945
J Neuropathol Exp Neurol. 1999 Apr;58(4):365-75
pubmed: 10218632
Curr Opin Neurobiol. 2018 Dec;53:162-173
pubmed: 30241058
J Biol Chem. 2010 Dec 31;285(53):41211-5
pubmed: 21071441
Eur J Neurosci. 2005 Jan;21(1):271-7
pubmed: 15654865
Exp Neurol. 1994 Jun;127(2):284-90
pubmed: 8033968
Nat Neurosci. 2009 Apr;12(4):387-9
pubmed: 19287387
J Neurosci. 2018 Apr 18;38(16):4031-4047
pubmed: 29567804
Exp Neurol. 2019 Oct;320:112961
pubmed: 31136762
Neuron. 2017 Jul 5;95(1):78-91.e5
pubmed: 28683272
Elife. 2017 Jan 17;6:
pubmed: 28095293
Cell Rep. 2019 Jun 11;27(11):3152-3166.e7
pubmed: 31189102
Neuro Oncol. 2012 Sep;14 Suppl 4:iv45-54
pubmed: 23095830
Proc Natl Acad Sci U S A. 2010 Mar 30;107(13):6064-9
pubmed: 20231460
Genes Dev. 2005 Jan 15;19(2):270-81
pubmed: 15625192
Sci Rep. 2013;3:2567
pubmed: 23995269
Science. 2015 Apr 24;348(6233):453-7
pubmed: 25908823
Neurosci Res. 2019 Feb;139:9-20
pubmed: 30006197
J Neurosci. 2006 Aug 16;26(33):8484-91
pubmed: 16914673
Cell Rep. 2013 May 30;3(5):1422-9
pubmed: 23665224
Exp Neurol. 2013 Aug;246:72-83
pubmed: 22285449
Neuron. 2013 Dec 4;80(5):1175-89
pubmed: 24210906
Neuron. 2006 Jun 15;50(6):869-81
pubmed: 16772169

Auteurs

Arnau Llobet Rosell (A)

Department of Fundamental Neurosciences, University of Lausanne, Rue du Bugnon 9, 1005 Lausanne, VD, Switzerland.

Lukas J Neukomm (LJ)

Department of Fundamental Neurosciences, University of Lausanne, Rue du Bugnon 9, 1005 Lausanne, VD, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH